AW
VNDA icon

Avion Wealth’s Vanda Pharmaceuticals VNDA Stock Holding History

Avion Wealth’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
140
– – ﹤0.01% 1763
2026
Q1 		$0 Hold
140
– – ﹤0.01% 1620
2025
Q4 		$1K Hold
140
– – ﹤0.01% 1154
2025
Q3 		$0 Hold
140
– – ﹤0.01% 1569
2025
Q2 		$0 Hold
140
– – ﹤0.01% 1632
2025
Q1 		$0 Buy
+140
New +$653 ﹤0.01% 1368
2024
Q4 		– Sell
-140
Closed – – 1290
2024
Q3 		$0 Hold
140
– – ﹤0.01% 1348
2024
Q2 		$0 Hold
140
– – ﹤0.01% 1270
2024
Q1 		$1K Hold
140
– – ﹤0.01% 1108
2023
Q4 		$1K Buy
+140
New +$565 ﹤0.01% 1004

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Avion Wealth's VNDA Position: Q2 2026 in Review

Avion Wealth held its Vanda Pharmaceuticals (VNDA) position steady in Q2 2026 at 140 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1763.

Avion Wealth first reported a position in VNDA in Q4 2023 and has held it in 10 quarters since. The position peaked at $1K in Q4 2025. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Avion Wealth held 140 shares of Vanda Pharmaceuticals worth $0 as of Q2 2026.
  • Avion Wealth left its Vanda Pharmaceuticals share count unchanged in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1763 holding.
  • Avion Wealth first reported a position in Vanda Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Avion Wealth's Vanda Pharmaceuticals position peaked at $1K in Q4 2025.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.